Miranda Bailey

Miranda Bailey has a diverse work experience spanning multiple companies and roles. Miranda is currently the Global Head of HEOR and Pricing at Rocket Pharmaceuticals since September 2022. Prior to this, they worked at Novartis Gene Therapies as an Executive Director from November 2020 to September 2022.

Miranda also has a significant experience at Novartis, where they held multiple positions including Director, Global Value and Access from October 2017 to November 2020, Market Access Manager from January 2014 to October 2017, and Senior Market Access Associate from December 2011 to January 2014.

Before joining Novartis, Miranda worked at Cochlear as a Health Outcomes Specialist from September 2010 to December 2011, and at GlaxoSmithKline Pharma GmbH as a Health Outcomes Specialist from December 2009 to September 2010.

Miranda'scareer started at IMS Health, where they worked as a Consultant from 2007 to 2009.

Miranda Bailey attended the University of New South Wales (UNSW) from 2000 to 2004. However, there is no information available regarding their degree or field of study during this time.